• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pharmaids Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3844.0
  • ISIN : INE117D01018
61.88 -1 (-1.84%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    60.04

  • Today’s High

    63.39

  • Open

    63.39

  • Perv Close

    63.04

  • 52W Low

    31.90

  • 52W High

    87.46

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    218.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.09

  • Debt-Equity Ratio

    -1.84

  • AGM Date

    30-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    218.24

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.27

  • BV (₹)

    18.10

  • Sales( ₹ in Cr.)

    2.34

  • NP (in Cr.)

    -7.28

  • NP Var(%)

    -47.0

  • Div%

    0.0

  • CPS (₹)

    -2.00

  • EPS (₹)

    -2.10

  • Traded Value (₹ in Lakhs)

    218.24

  • 52 Week High

    87.46

  • 52 Week Low

    31.90

  • Price BSE

    62.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    218.24

  • P/C Ratio

    -30.90

  • P/E Ratio

    -30.00

  • Price Vs.BV

    -2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.03 0.00 3.94 8.55 0.00 0.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.03 0.00 3.94 8.55 0.00 0.56
Other Income 0.80 0.00 0.02 0.03 0.00 0.01
Stock Adjustments 0.23 -0.89 0.52 0.37 0.00 0.00
Total Income 1.06 -0.89 4.48 8.95 0.00 0.57
EXPENDITURE :            
Raw Materials 0.25 0.00 4.09 8.53 0.00 0.36
Power and Fuel Cost 0.01 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.99 1.13 0.04 0.04 0.02 0.05
Other Manufacturing Expenses 0.04 0.02 0.00 0.00 0.01 0.00
Selling and Administration Expenses 1.45 0.80 0.19 0.23 0.23 0.20
Miscellaneous Expenses 2.88 7.06 0.00 0.01 0.07 0.06
Employee Benefit Expenses 1.99 1.13 0.04 0.04 0.02 0.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.62 9.00 4.32 8.82 0.34 0.67
Operating Profit -5.58 -9.89 0.15 0.13 -0.34 -0.10
Interest 0.33 0.00 0.00 0.00 0.00 0.00
Gross Profit -5.91 -9.89 0.15 0.13 -0.34 -0.10
Depreciation 0.18 0.02 0.01 0.04 0.04 0.05
Profit Before Tax -6.09 -9.91 0.14 0.09 -0.38 -0.15
Current Tax 0.00 0.00 0.00 0.00 0.00 0.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.14 -2.35 0.00 0.00 -0.41 0.00
Reported Net Profit -4.95 -7.56 0.15 0.09 0.03 -0.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.95 -7.56 0.15 0.09 0.03 -0.18
Adjustment below Net Profit -0.04 0.00 0.00 0.00 0.00 -0.01
P & L Balance brought forward -9.89 -2.33 -2.48 -2.57 -2.61 -2.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -14.88 -9.89 -2.33 -2.48 -2.57 -2.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.40 -3.52 0.14 0.09 0.03 0.00
Earnings Per Share(Adj)-Unit Curr -1.40 -3.52 0.14 0.09 0.03 0.00
Book Value 20.15 10.46 8.44 8.30 8.21 8.18
Book Value(Adj)-Unit Curr 20.15 10.46 8.44 8.30 8.21 8.18

Shareholding Pattern

  • Promoter Group

    5.22%

  • Public Share Holding

    94.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,840,429 5.22 1,840,429 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,840,429 5.22 1,840,429 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,690,845 4.79 1,690,845 26
Clearing Members 200 0.00 200 1
Directors of their Relatives 14,398,756 40.83 14,398,756 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 501,167 1.42 501,167 40
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,350,172 26.51 9,292,672 62
Individuals holding nominal share capital up to Rs. 1 lakh 3,553,053 10.07 2,545,502 8,068
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,130,612 3.21 1,130,612 4
Sub Total 33,427,383 94.78 32,362,332 8,207
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,267,812 100.00 34,202,761 8,220

Company Background

Pharmaids Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Pharmaids Pharmaceuticals Ltd
  • BSE Code : 3844.0
  • ISIN : INE117D01018

  • Incorporation Year

    1989

  • Registered Office

    4-4-211/212/3 1st Floor
    Inderbagh Sulthan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-66669809

  • FAX

    91-40-23232348

  • Chairman

    Shankarappa Nagaraja Vinaya Babu

  • Managing Director

  • Company Secretary

    Prasanna Subramanya Bhat.

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Pharmaids Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pharmaids Pharma 61.88 0.82 0.03 -30.04 0.00
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92